Mary Chance
Family · Kingfisher, OKNPI 1083190896
Payments from drug & device makers
Across 162 payments — averaging $15.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$526
- Boehringer Ingelheim$178
- Otsuka America Pharmaceutical, Inc.$172
- Axsome Therapeutics, Inc.$150
- AstraZeneca$149
- Biohaven Pharmaceutical Holding Company Ltd.$143
- plus $1K from 26 others
What the payments were for
- Food & beverage$2,555100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 45 | $526 |
| Boehringer Ingelheim | 10 | $178 |
| Otsuka America Pharmaceutical, Inc. | 9 | $172 |
| Axsome Therapeutics, Inc. | 8 | $150 |
| AstraZeneca | 10 | $149 |
| Biohaven Pharmaceutical Holding Company Ltd. | 9 | $143 |
| Pfizer | 9 | $137 |
| Amgen(2 entities) | 8 | $135 |
| Lilly USA, LLC | 8 | $132 |
| Sunovion Pharmaceuticals Inc. | 6 | $105 |
| Novo Nordisk | 4 | $73 |
| Biohaven Pharmaceuticals, Inc. | 4 | $62 |
| GSK | 3 | $56 |
| Xeris Pharmaceuticals, Inc. | 3 | $50 |
| Astellas Pharma US Inc | 3 | $50 |
| Bayer | 2 | $46 |
| Supernus Pharmaceuticals, Inc. | 2 | $45 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $43 |
| Sumitomo Pharma America, Inc. | 2 | $39 |
| Amarin Pharma, Inc. | 2 | $34 |
| Dexcom, Inc. | 2 | $31 |
| Globus Medical | 1 | $25 |
| Genentech USA, Inc. | 1 | $22 |
| Antares Pharma, Inc. | 1 | $21 |
| Halozyme Inc | 1 | $20 |
| Lundbeck LLC | 1 | $20 |
| Johnson & Johnson | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
| Novartis | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $11 |
How this compares
$2,555 in reported general payments places this provider in the 85th percentile of 2,026 family providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 31 | $33,587 |
| EliquisApixaban | 20 | $13,305 |
| OzempicSemaglutide | 13 | $11,822 |
| JardianceEmpagliflozin | 16 | $11,783 |
| RybelsusSemaglutide | 11 | $9,422 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 25 | $658 |
| Atorvastatin Calcium | 59 | $513 |
| Omeprazole | 19 | $432 |
| Levothyroxine Sodium | 42 | $378 |
| Duloxetine Hcl | 13 | $354 |
| Celecoxib | 24 | $291 |
| Gabapentin | 38 | $272 |
| Lisinopril | 35 | $209 |
| Enalapril Maleate | 14 | $205 |
| Fluticasone Propionate | 18 | $193 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $132 | $33,58731 claims |
| Novo NordiskOzempic, Rybelsus | $73 | $21,24424 claims |
| PfizerEliquis | $137 | $13,30520 claims |
| Boehringer IngelheimJardiance | $178 | $11,78316 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,026 family providers in Oklahoma.
Other family in Kingfisher
- April WilcoxOklahoma City$245K
- Jeremy MorganOklahoma City$63K
- Samantha BellingerOklahoma City$39K
- Candy WilliamsTulsa$22K
- Lacey HillOklahoma City$20K
- Shelby WrightStillwater$17K
- Brandy ReevesNorman$17K
- Amanda OblanderYukon$17K
- Julia John SamuelOklahoma City$17K
- Jillian OakleafTulsa$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.